'Pharma companies don't want any regulation'
Clinical trials in India have for long been inviting controversy due to lack of transparency and regulatory mechanism. While replying to a question in Rajya Sabha in March 2013, the then Union Health Minister Ghulam Nabi Azad said 438 deaths took place during clinical trials in 2011 while 668 people died during 2010. While hearing the public interest litigation (PIL) filed by Swasthya Adhikar Manch in 2012, the Supreme Court asked the Central government to come up with more stringent regulatory and monitoring set up to stop exploitation